In colorectal cancer, liver metastasis, CD4+FOXP3+ Tregs, and increased levels of α-smooth muscle actin, HGF, and c-MET indicate potential therapeutic targets for this metastatic form of colorectal cancer. Here, MET is linked to colorectal cancer.